aKTIV8 Platform Features

← LLM Index · Last updated: July 2026

1. Company Intelligence

The core of aKTIV8 is a live database of 35,000+ life sciences companies with continuously updated profiles.

• Company search and discovery with filters by therapeutic area, stage, geography, modality
• Pipeline asset tracking — drugs, biologics, and devices in development
• Clinical trial history sourced from ClinicalTrials.gov
• Funding round history with investor relationships
• News and signal aggregation per company
• Recency scoring — companies with recent signals surface first
• Company status tracking (public, private, acquired, closed)

2. Catalyst & Regulatory Calendar

aKTIV8 tracks FDA and global regulatory events (PDUFA dates, advisory committees, NDA/BLA submissions) and links them to company profiles.

• PDUFA date calendar with company and asset linkage
• Historical catalyst data (FDA decisions, approvals, rejections, CRLs)
• Real-time signal generation when regulatory events occur
• Conference and advisory committee tracking

3. News & Signal Feed

Industry news is collected from 20+ RSS feeds every 6 hours and categorised by signal type.

• Sources: FierceBiotech, STAT News, Endpoints News, BioSpace, BioWorld, GlobeNewswire, PR Newswire, and more
• Signal types: Clinical Trials, Funding, Regulatory, Partnerships, Approvals
• Keyword matching to company profiles
• Public news feed at /news (no login required)
• Updates page (in-platform) merging signals with user CRM activity

4. HAKASE AI Intelligence Engine

HAKASE is aKTIV8's AI orchestrator, built on a multi-model routing system.

• Natural language questions answered about companies, pipelines, markets
• Responses grounded strictly in platform data — no fabricated citations
• BD outreach email drafting with company-specific grounding
• Market analysis and competitive landscape reports
• Asset valuation and partnership opportunity scoring
• Supports OpenAI, Anthropic Claude, and Kimi models
• Public demo at /hakase

5. Daily Intelligence Brief

An AI-written daily digest, delivered each morning before market open (7:00 AM Gulf time / 3:00 AM UTC).

• Covers the day's top catalysts, funding events, regulatory decisions, and partnerships
• HAKASE Analysis section: AI narrative grounded in that day's signals
• Shareable public link for each day's brief
• Email subscription available
• Archive at /brief/[YYYY-MM-DD]

6. Product Pipeline Monitor

Visual pipeline tracking across the industry, filterable by stage and therapeutic area.

• Buckets companies by most-advanced pipeline stage (Preclinical → Phase 1 → Phase 2 → Phase 3 → Approved)
• Asset-level view with mechanism, modality, indication, and partner information
• Deep-link from any asset to the originating company profile

7. Investor & Funding Intelligence

Funding rounds and investor relationships are tracked and aggregated.

• Funding round history per company (Series A/B/C, IPO, venture debt, grants)
• Investor profiles with portfolio company lists
• Aggregate deal flow analytics
• NIH SBIR/STTR grant tracking

8. Contact & CRM Layer

Lightweight CRM for BD professionals, integrated with intelligence data.

• Contact discovery via Hunter.io email enrichment
• BD outreach tracking (sent emails, engagement)
• Company-level research notes
• Activity feed combining CRM events with platform signals

9. Geographic Intelligence

Specialised intelligence modules for key emerging markets.

• MEA (Middle East & Africa) BD intelligence module
• India pharma and biotech intelligence module
• Geo-scoped user access control
• Trade feed and regional news integration

10. Reports & Exports

• AI-generated BD brief reports (target assessment, opportunity scan, market analysis)
• Company-level exports
• Batch company import and enrichment pipeline

← Back to LLM Index